JP2004520292A5 - - Google Patents

Download PDF

Info

Publication number
JP2004520292A5
JP2004520292A5 JP2002547905A JP2002547905A JP2004520292A5 JP 2004520292 A5 JP2004520292 A5 JP 2004520292A5 JP 2002547905 A JP2002547905 A JP 2002547905A JP 2002547905 A JP2002547905 A JP 2002547905A JP 2004520292 A5 JP2004520292 A5 JP 2004520292A5
Authority
JP
Japan
Prior art keywords
imidazole
alkyl
phenylethynyl
methyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002547905A
Other languages
English (en)
Japanese (ja)
Other versions
JP4077317B2 (ja
JP2004520292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/013714 external-priority patent/WO2002046166A1/en
Publication of JP2004520292A publication Critical patent/JP2004520292A/ja
Publication of JP2004520292A5 publication Critical patent/JP2004520292A5/ja
Application granted granted Critical
Publication of JP4077317B2 publication Critical patent/JP4077317B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002547905A 2000-12-04 2001-11-26 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体 Expired - Fee Related JP4077317B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00126615 2000-12-04
PCT/EP2001/013714 WO2002046166A1 (en) 2000-12-04 2001-11-26 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007325072A Division JP2008169206A (ja) 2000-12-04 2007-12-17 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体

Publications (3)

Publication Number Publication Date
JP2004520292A JP2004520292A (ja) 2004-07-08
JP2004520292A5 true JP2004520292A5 (https=) 2005-05-26
JP4077317B2 JP4077317B2 (ja) 2008-04-16

Family

ID=8170567

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002547905A Expired - Fee Related JP4077317B2 (ja) 2000-12-04 2001-11-26 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体
JP2007325072A Pending JP2008169206A (ja) 2000-12-04 2007-12-17 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007325072A Pending JP2008169206A (ja) 2000-12-04 2007-12-17 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体

Country Status (31)

Country Link
US (4) US6706707B2 (https=)
EP (1) EP1349839B8 (https=)
JP (2) JP4077317B2 (https=)
KR (1) KR100515549B1 (https=)
CN (1) CN1257894C (https=)
AR (1) AR035401A1 (https=)
AT (1) ATE288898T1 (https=)
AU (2) AU2956702A (https=)
BG (1) BG107877A (https=)
BR (1) BR0115871A (https=)
CA (1) CA2430696C (https=)
CZ (1) CZ20031795A3 (https=)
DE (1) DE60108900T2 (https=)
DK (1) DK1349839T3 (https=)
EC (1) ECSP034640A (https=)
ES (1) ES2248410T3 (https=)
HR (1) HRP20030429A2 (https=)
HU (1) HUP0400570A3 (https=)
IL (2) IL155999A0 (https=)
MA (1) MA26971A1 (https=)
MX (1) MXPA03004862A (https=)
NO (1) NO324326B1 (https=)
NZ (1) NZ525917A (https=)
PL (1) PL366222A1 (https=)
PT (1) PT1349839E (https=)
RS (1) RS43903A (https=)
RU (1) RU2284323C9 (https=)
SI (1) SI1349839T1 (https=)
SK (1) SK8402003A3 (https=)
WO (1) WO2002046166A1 (https=)
ZA (1) ZA200303870B (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128996D0 (en) 2001-12-04 2002-01-23 Novartis Ag Organic compounds
AU2003264018A1 (en) 2002-08-09 2004-02-25 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors
MXPA05001592A (es) * 2002-08-09 2005-05-05 Astrazeneca Ab Oxadiazoles como moduladores de receptor-5 de glutamato metabotropico.
IL166510A0 (en) 2002-08-09 2006-01-15 Nps Pharma Inc 1,2,4"oxadiazole as modulators of metabotropic glutamate receptor-5
ITMI20030151A1 (it) * 2003-01-30 2004-07-31 Recordati Ind Chimica E Farma Ceutica S P A Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore.
ES2316968T3 (es) 2003-03-04 2009-04-16 Addex Pharma Sa Nuevos derivados de aminopiridina utilizados como antagonistas de mglur5.
CA2517081A1 (en) 2003-03-07 2004-09-16 Astellas Pharma Inc. Nitrogen-containing heterocyclic derivatives having 2-6, disubtituted styryl
TWI292318B (en) 2003-03-10 2008-01-11 Hoffmann La Roche Imidazol-4-yl-ethynyl-pyridine derivatives
JP2006521358A (ja) * 2003-03-26 2006-09-21 メルク エンド カムパニー インコーポレーテッド 代謝調節型グルタミン酸受容体のベンズアミドモジュレータ
US7531529B2 (en) 2003-06-05 2009-05-12 Roche Palo Alto Llc Imidazole derivatives
UA80888C2 (en) * 2003-06-05 2007-11-12 Hoffmann La Roche Imidazole derivatives as glutmate receptor antagonists
WO2004111040A1 (en) * 2003-06-12 2004-12-23 F. Hoffmann-La Roche Ag Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
US7915424B2 (en) * 2004-03-22 2011-03-29 Eli Lilly And Company Pyridyl derivatives and their use as mGlu5 antagonists
MY149038A (en) * 2004-05-26 2013-07-15 Eisai R&D Man Co Ltd Cinnamide compound
EP1756086B1 (en) * 2004-06-01 2008-06-04 F.Hoffmann-La Roche Ag Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists
KR100907108B1 (ko) * 2004-06-01 2009-07-09 에프. 호프만-라 로슈 아게 Mglu5 수용체 길항제로서 피리딘-4-일-에틴일-이미다졸및 피라졸
GB0413605D0 (en) 2004-06-17 2004-07-21 Addex Pharmaceuticals Sa Novel compounds
DE102004044884A1 (de) 2004-09-14 2006-05-24 Grünenthal GmbH Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
CA2580119A1 (en) 2004-10-26 2006-05-04 Eisai R & D Management Co., Ltd. Amorphous object of cinnamide compound
KR20070106690A (ko) * 2004-12-27 2007-11-05 아스트라제네카 아베 피라졸론 화합물 및 대사성 글루타메이트 수용체길항제로서 그들의 용도
CA2601098C (en) * 2005-03-16 2011-07-05 Aventis Pharmaceuticals Inc. Dipyrazoles as central nervous system agents
DE602006012815D1 (de) 2005-03-23 2010-04-22 Hoffmann La Roche Acetylenylpyrazolopyrimidinderivate als mglur2-antagonsten
GB0508319D0 (en) 2005-04-25 2005-06-01 Novartis Ag Organic compounds
AU2006316005A1 (en) * 2005-11-18 2007-05-24 Eisai R & D Management Co., Ltd. Process for production of cinnamamide derivative
EP1953151A4 (en) * 2005-11-18 2010-06-02 Eisai R&D Man Co Ltd SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF
RU2381225C1 (ru) * 2005-11-24 2010-02-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Производное циннамида типа морфолина
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
EP1965780B1 (en) * 2005-12-19 2017-03-08 The University Of Liverpool Propofol derivatives as analgesics
DE102005062985A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte bis(hetero)aromatische N-Ethylpropiolamide und ihre Verwendung zur Herstellung von Arzneimitteln
TWI378091B (en) * 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
AR059955A1 (es) * 2006-03-09 2008-05-14 Eisai R&D Man Co Ltd Compuestos policiclicos no peptidicos, medicamentos que los contienen, y usos para prevenir o tratar enfermedades causadas por la produccion de beta amiloide
DE102006011574A1 (de) 2006-03-10 2007-10-31 Grünenthal GmbH Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln
AR062095A1 (es) * 2006-07-28 2008-10-15 Eisai R&D Man Co Ltd Profarmaco de compuesto cinamida
ES2577391T3 (es) 2006-12-21 2016-07-14 F. Hoffmann-La Roche Ag Polimorfos de un antagonista del receptor mglur5
CL2008000582A1 (es) 2007-02-28 2008-06-27 Eisai R&D Man Co Ltd Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis.
WO2008140111A1 (ja) * 2007-05-16 2008-11-20 Eisai R & D Management Co., Ltd. シンナミド誘導体のワンポット製造方法
ES2529648T3 (es) 2007-08-31 2015-02-24 Eisai R&D Management Co., Ltd. Compuesto policíclico
US7935815B2 (en) * 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
US20100317860A1 (en) * 2008-01-28 2010-12-16 Ikuo Kushida Crystalline cinnamide compounds or salts thereof
US8323805B2 (en) 2009-06-04 2012-12-04 Nitto Denko Corporation Emissive aryl-heteroaryl acetylenes
US8334287B2 (en) 2009-07-17 2012-12-18 Hoffmann-La Roche Inc. Imidazoles
US8642626B2 (en) 2010-07-29 2014-02-04 Taisho Pharmaceutical Co., Ltd. Ethinyl-pyrazole derivative
HUE040156T2 (hu) * 2010-11-05 2019-02-28 Oat Agrio Co Ltd Etinilfenilamidinvegyület vagy sója, eljárás azok elõállítására, és fungicid mezõgazdasági és kertészeti alkalmazásra
WO2012172093A1 (en) * 2011-06-17 2012-12-20 Merz Pharma Gmbh & Co. Kgaa Dihydroindolizine derivate as metabotropic glutamate receptor modulators
KR101291037B1 (ko) * 2011-10-12 2013-08-01 사회복지법인 삼성생명공익재단 레스베라트롤 유도체와 스티릴-오각형 방향족 화합물 및 이들의 베타-아밀로이드 플라그에 대한 결합제 및 진단영상제의 용도
WO2017117708A1 (en) 2016-01-05 2017-07-13 Hua Medicine (Shanghai) Ltd. Pyrazole derivatives
US10669255B2 (en) 2016-04-06 2020-06-02 Hua Medicine (Shanghai) Ltd. Pyrrole derivatives
AU2018208422B2 (en) 2017-01-10 2021-11-11 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
CA3066711A1 (en) 2017-07-31 2019-02-07 Novartis Ag Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use
US12479816B2 (en) 2019-02-08 2025-11-25 University of Pittsburgh—of the Commonwealth System of Higher Education 20-HETE formation inhibitors
JP2023504177A (ja) 2019-12-02 2023-02-01 エフ.ホフマン-ラ ロシュ アーゲー アルキニル-(ヘテロアリール)-カルボキサミドhcn1阻害剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303199A (en) 1963-07-15 1967-02-07 Geigy Chem Corp Certain imidazolone derivatives and process for making same
US3341548A (en) 1964-04-29 1967-09-12 Hoffmann La Roche Nitroimidazoles and their preparation
DE2035905A1 (de) * 1970-07-20 1972-02-03 Chemische Fabrik Stockhausen & Cie.,4150Krefeld Imidazolverbindungen und deren Herstellungsverfahren
CA1174673A (en) 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
US4711962A (en) 1984-10-18 1987-12-08 Stauffer Chemical Company Process for selective preparation of ratios of isomers formed on N-substitution of asymmetric imidazoles
EP0479903B1 (en) 1989-06-30 1996-02-21 E.I. Du Pont De Nemours And Company Substituted imidazoles useful as angiotensin ii blockers
US5821937A (en) * 1996-02-23 1998-10-13 Netsuite Development, L.P. Computer method for updating a network design
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
PL192029B1 (pl) * 1997-08-14 2006-08-31 Hoffmann La Roche Zastosowanie heterocyklicznych eterów winylowych, nowe heterocykliczne etery winylowe, sposób ich wytwarzania i środek farmaceutyczny
US6377987B1 (en) * 1999-04-30 2002-04-23 Cisco Technology, Inc. Mechanism for determining actual physical topology of network based on gathered configuration information representing true neighboring devices
EP1214303A1 (en) * 1999-08-31 2002-06-19 Merck & Co., Inc. Heterocyclic compounds and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2004520292A5 (https=)
RU2003119548A (ru) Фенилэтенил-или фенилэтенилпроизводные в качестве антагонистов глутаматного рецептора
JP2004523535A5 (https=)
JP2003510359A5 (https=)
TWI268925B (en) 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
JP2005509632A5 (https=)
IL160945A (en) 4, 5 - diarylthiazole - 2 - carboxamides having cb1 - antagonistic, agonistic or partial agonistic activity and use thereof for the preparation of pharmaceutical compositions
JP2006501201A5 (https=)
JP2002540155A5 (https=)
JP2005536475A5 (https=)
RU2005131165A (ru) Производные имидазол-4-илэтинилпиридина
JP2009525340A5 (https=)
JP2014502979A5 (https=)
JP2007511485A5 (https=)
JP2005533835A5 (https=)
JP2004525965A5 (https=)
JP2006501306A5 (https=)
JP2007502265A5 (https=)
JP2005526696A5 (https=)
CN102223882B (zh) 用于治疗肥厚型心肌病的III 型磷酸二酯酶(PPE III)抑制剂或Ca2+敏化剂
JP2002505286A5 (https=)
JP2004521150A5 (https=)
JP2004524279A5 (https=)
JP2004520424A5 (https=)
JP2004525184A5 (https=)